Skip to main content
OpenTrials
Completed

NCT Number: NCT05040672

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees

Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of a pharmaceutical company.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Augusto Figueiredo

São Paulo, 01140050, Brazil

About this study

In Brazil, there are still few published and current studies that explore man's attention and awareness of health. Historically, women attend medical appointments and perform routine tests more frequently than men. For this is very important Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of Libbs Farmacêutica (a pharmaceutical company in Brazil).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male individuals included in the Libbs workforce;
  • Age 18 years or older;
  • Subjects who agree to participate in the study after reading and signing the Informed Consent Form.

Exclusion criteria

  • There is no exclusion criteria

Treatment and study plan

questionare online application

Behavioral

questionare online application

Primary outcomes

  1. Evaluation of Knowledge and Practice About Prostate Cancer e Healthy Habits

    Time frame: 1 month

    Assess the subjects knowledge and practice in relation to educational campaigns aimed at prostate cancer.All the information wil be collected using a questionnaire previously approved by the ethics committee.

Sponsors and collaborators

Lead sponsor

Libbs Farmacêutica LTDA

Industry

Registry information

Official study title

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees of Libbs Pharmaceuticals

Acronym: LB2008

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 10, 2021
Registry last updated
Aug 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.